How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
Rigel Pharmaceuticals stock has seen its fair value estimate tick up to $49.60 from $46.60, underpinned by stronger long term revenue growth assumptions of about 9.8% versus 8.8% previously. At the same time, a slightly higher discount rate of 7.12% versus 7.12% reflects a modestly increased risk backdrop, even as analysts become more constructive on the company's trajectory. Stay tuned to see how you can track these evolving targets and follow the changing narrative around Rigel Pharmaceuticals.
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and ExpositionPR Newswire
- Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Rigel to Present at the Piper Sandler 37th Annual Healthcare ConferencePR Newswire
- Rigel Pharmaceuticals: Behind The Huge Rally [Seeking Alpha]Seeking Alpha
RIGL
Earnings
- 11/4/25 - Beat
RIGL
Sec Filings
- 12/10/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/4/25 - Form 8-K
- RIGL's page on the SEC website